Combination of amoxycillin and clavulanate for treatment of drug-resistant streptococcus pneumonia

摘要

Infections potentially caused by DRSP may be treated by a method which comprises administering a pharmaceutical formulation comprising either for an adult or older child patient 1000±10% mg amoxycillin and 125±10% mg clavulanate; in combination with a pharmaceutically acceptable carrier or excipient, three times a day (tid).